HomeToday’s HighlightsThe Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. The Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. Today’s Highlights April 8, 2019 The Amgen/Novartis Story In May 2018 Amgen (AMGN) & Novartis (This content is for paid subscribers. Please click here to subscribe or here to log in. Today’s Highlights Alder BioPharmaceuticals (ALDR), Amgen (AMGN), Novartis (NVS) April 8, 2019 Tweet Pin It Other Articles Merck to Acquire Cidara Therapeutics Inc Diversifying Its Portfolio To Include Late-Phase Antiviral Agent November 14, 2025 0 Cidara Therapeutics Provides Corporate Update and Reports Q3 2025 Results November 7, 2025 0 Knowing What Cidara Therapeutics is Doing for the Seasonal Flu October 28, 2025 0 BridgeBio Pharma Reported Positive Phase 3 Results from FORTIFY the Phase 3 Pivotal Study of BBP-418 in People with Limb-Girdle Muscular Dystrophy Type 2I/R9 October 27, 2025 0